Insider trades
Thomas Sciascia, Chief Officer of Trevi Therapeutics TRVI, has filed 0 purchases and 6 sales on the open market. The latest trade was on 02/19.
Thomas Sciascia
Chief Scientific Officer
- Company
- Trevi Therapeutics TRVI
- First filing
- 23/02/16
- Trades
- 24 trades
- Buys / sales
- 0 / 6
- 12-month net buying
- No record
- Last trade
- 02/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/03/25 | 25/03/26 | 2,631 sh | $6.60 | $17,364.6 | −1.2% | |
| Open-market sale | 24/08/19 | 24/08/21 | 16,496 sh | $2.96 | $48,828.16 | −7.0% | |
TRVI | Open-market sale | 24/08/14–24/08/16 | 24/08/16 | 31,505 sh3 trades | $2.77avg. | $87,335.15 | −12.5% |
| Open-market sale | 24/05/29 | 24/05/31 | 53,368 sh | $2.55 | $136,088.4 | −19.9% |